Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content
Simon kyle named nihr oxford brc senior research fellow

Simon Kyle named NIHR Oxford BRC Senior Research Fellow

Award Ophthalmology SCNi

The Oxford BRC is delighted to announce the appointment of seven new Senior Research Fellows.

Later school start time trialled in teensleep project

Later school start time trialled in Teensleep Project

Ophthalmology Public engagement Research

Researchers in our Sleep and Circadian Neuroscience Institute are working with Havant & South Downs College on a teenage sleep study.

World2019s first gene therapy operation for common cause of sight loss carried out

World’s first gene therapy operation for common cause of sight loss carried out

Ophthalmology Research

Researchers in Oxford have carried out the world’s first gene therapy operation to tackle the root cause of age-related macular degeneration (AMD), the UK’s most common cause of sight loss.

Award success for msc in sleep medicine student

Award success for MSc in Sleep Medicine student

Award Ophthalmology SCNi

Priya Maharaj has won the Archibald Jackson Prize from Somerville College for achieving a Distinction in the MSc in Sleep Medicine.

Ndcn welcomes ocular oncologist

NDCN welcomes ocular oncologist

Ophthalmology

Bertil Damato will oversee the provision of clinical care to patients with an ocular tumour and develop a research group to focus on ocular melanoma and other eye tumours.

Gene therapy breakthrough in treating a rare form of blindness

Gene therapy breakthrough in treating a rare form of blindness

Ophthalmology Research

The positive results of the world’s first gene therapy trial for a genetic cause of blindness known as choroideremia have been reported in this week’s edition of Nature Medicine.

Digital insomnia medicine rolled out as major study links sleep to better health

Digital insomnia medicine rolled out as major study links sleep to better health

Ophthalmology Research

Millions of people are to be given access to digital treatment for insomnia as an alternative to sleeping pills. Study by Colin Espie et al shows that Sleepio improves wellbeing in nearly three quarters of participants.

First human test of robotic eye surgery a success

First human test of robotic eye surgery a success

Ophthalmology Research

The first trial of robot-assisted eye surgery in patients has shown the technique to be both safe and effective.

Sleep scientists collaborate with nightshift workers on art project

Sleep scientists collaborate with nightshift workers on art project

Ophthalmology SCNi

Researchers at the Sleep and Circadian Neuroscience Institute (SCNi) have been working with visual artist Martin Kohout to reveal the stories of the night-shift workers who keep London running.

Gene therapy shows promise for reversing blindness

Gene therapy shows promise for reversing blindness

Ophthalmology Research

In a laboratory study in Oxford, researchers have shown how it might be possible to reverse blindness using gene therapy to reprogram cells at the back of the eye to become light sensitive.

New trial for blindness rewrites the genetic code

New trial for blindness rewrites the genetic code

Ophthalmology

Researchers have started a new gene therapy clinical trial to treat X-linked retinitis pigmentosa (XLRP), the most common cause of blindness in young people.

New spinout addresses sleep and circadian rhythm disruption

New spinout addresses sleep and circadian rhythm disruption

Ophthalmology SCNi

Circadian Therapeutics has been established to identify and bring to market pharmaceutical and diagnostic platforms for the effective management of physiological and pathological conditions through their ability to modify the body's circadian rhythms.

Second phase of gene therapy trial for blindness under way

Second phase of gene therapy trial for blindness under way

Ophthalmology Research

The trial involves injecting a virus into the eye to deliver billions of healthy genes to replace a key missing gene for choroideremia sufferers.

World first for robot eye operation

World first for robot eye operation

Ophthalmology

University of Oxford surgeons at Oxford's John Radcliffe Hospital have performed the world's first operation inside the eye using a robot.

Spinout develops smart glasses

Spinout develops smart glasses

Clinical Neurology Ophthalmology Research

A spinout company from our Department, OxSight, has reported that in a recent UK-wide trial its smart glasses helped sight impaired and blind people to navigate independently, avoid collisions and see in the dark.

Lighting colour affects sleep and wakefulness

Lighting colour affects sleep and wakefulness

Ophthalmology Research

Our researchers have shown how different colours of light could affect our ability to sleep.

Gene therapy shows long term benefit for treating blindness

Gene therapy shows long-term benefit for treating blindness

Ophthalmology

Pioneering gene therapy has restored some vision to John Radcliffe Hospital patients with a rare form of genetic blindness for as long as four years, raising hopes it could be used to cure common causes of vision loss, new University of Oxford research published today shows.

Public missing out on a night2019s worth of sleep every week

Public missing out on a night’s worth of sleep every week

Ophthalmology

Experts call for introduction of sleep guidelines in new report

Load More